Cargando…
Comparative Immunomodulatory Evaluation of the Receptor Binding Domain of the SARS-CoV-2 Spike Protein; a Potential Vaccine Candidate Which Imparts Potent Humoral and Th1 Type Immune Response in a Mouse Model
The newly emerged novel coronavirus, SARS-CoV-2, the causative agent of COVID-19 has proven to be a threat to the human race globally, thus, vaccine development against SARS-CoV-2 is an unmet need driving mass vaccination efforts. The receptor binding domain of the spike protein of this coronavirus ...
Autores principales: | Shrivastava, Tripti, Singh, Balwant, Rizvi, Zaigham Abbas, Verma, Rohit, Goswami, Sandeep, Vishwakarma, Preeti, Jakhar, Kamini, Sonar, Sudipta, Mani, Shailendra, Bhattacharyya, Sankar, Awasthi, Amit, Surjit, Milan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182375/ https://www.ncbi.nlm.nih.gov/pubmed/34108961 http://dx.doi.org/10.3389/fimmu.2021.641447 |
Ejemplares similares
-
Characterization of a broadly cross reactive tetravalent human monoclonal antibody, recognizing conformational epitopes in receptor binding domain of SARS-CoV-2
por: Garg, Sonal, et al.
Publicado: (2022) -
Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitro
por: Vishwakarma, Preeti, et al.
Publicado: (2021) -
Non-neutralizing SARS CoV-2 directed polyclonal antibodies demonstrate cross-reactivity with the HA glycans of influenza virus
por: Murugavelu, Praveenkumar, et al.
Publicado: (2021) -
The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41
por: Perween, Reshma, et al.
Publicado: (2021) -
Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19
por: Rizvi, Zaigham Abbas, et al.
Publicado: (2021)